The cluster is dominated by passive rebalancing with no active hedge fund or family office involvement. This provides no actionable directional signal. Monitor for filings from active managers or insiders for higher-conviction reads.
Executive Summary
An institutional cluster for KalVista Pharmaceuticals shows 4 passive buyers (Wells Fargo, Schwab, Morgan Stanley, UBS) adding $9.4M in net new holdings and 1 passive seller (Fidelity) trimming $384K. However, all participants are mega-passive index funds, indicating routine rebalancing rather than a fundamental thesis. The net buying is modest relative to the $1.4B market cap, and historical 13F-based reads on KALV have underperformed.
Key Financial Metrics
Institutional Positions
Net institutional flow: $9.0M
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Wells Fargo | ADD | +47.1% | $454.0K | $167.0K |
| Schwab | DOUBLED | +183.7% | $3.9M | $2.6M |
| Morgan Stanley | DOUBLED | +135.7% | $6.9M | $4.2M |
| UBS | ADD | +66.4% | $5.5M | $2.4M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Fidelity | TRIM | -30.8% | $1.5M | -$384.9K |
Key Facts
- 4 passive buyers added $9.4M net; 1 passive seller trimmed $384K.
- All participants are mega-passive/index funds, reducing signal strength.
- Net institutional buying represents ~0.6% of market cap.
Financial Impact
Total institutional accumulation of approximately $9.0M net, or ~0.6% of KALV's $1.4B market cap.
Risk Factors
- Passive flow is not fundamental conviction; positions may reverse next quarter.
- Historical KALV 13F cluster readthrough has been poor (avg -7% T+20).
- Low impact score reflects minimal new information.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-KALV-2025-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 22, 2026 14w ago | 15-12G | — | awaiting T+1 | — | — |
Jun 17, 2026 15w ago | EFFECT | $27.00 awaiting T+1 | awaiting T+1 | — | — |
Jun 11, 2026 16w ago | 8-K | $26.99 awaiting T+1 | awaiting T+1 | — | — |
Jun 11, 2026 16w ago | Institutional Cluster | $27.00 $27.00 | · 0.00% | ▼ −0.54% | — |
May 19, 2026 19w ago | Insider Cluster | $26.81 $26.77 | ▲ +0.15% | ▲ +0.34% | — |
May 19, 2026 19w ago | Insider Cluster | $26.81 $26.77 | ▼ −0.15% | ▼ −0.34% | — |
Apr 29, 2026 22w ago | 8-K | $26.67 $26.66 | ▼ −0.04% | ▼ −1.06% | — |
Apr 17, 2026 24w ago | Insider Cluster | $20.48 $20.87 | ▼ −1.90% | ▼ −2.10% | — |
Feb 23, 2026 31w ago | Insider Cluster | $15.56 $15.77 | ▼ −1.35% | ▼ −0.61% | — |
Feb 23, 2026 31w ago | Insider Cluster | $15.56 $15.77 | ▼ −1.35% | ▼ −0.61% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access